Scientists check how donor skin graft heals in breast reconstruction
NCT ID NCT05744414
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines how AlloMend®, a graft made from donated human skin, integrates with a patient's own tissue during breast reconstruction. Researchers will analyze tissue samples from 30 women who had the graft placed with a tissue expander, looking for signs of cell growth, blood vessel formation, and healing. The goal is to better understand how the body accepts the graft, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AlloMend® acellular dermal matrix (a graft material made from donated human skin, processed to support tissue regeneration)
- What this could lead to
- If successful, this study could confirm that AlloMend® safely integrates with the body, supporting its use in breast reconstruction procedures.
- What could go wrong
- This is a small, early-stage study (30 participants) focused on tissue analysis, not on proving clinical benefits. Results may not apply to all patients or guarantee better outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST IMPLANT; COMPLICATIONS, INFECTION OR INFLAMMATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Janiga MDs Plastic Surgery and Cosmetic Center
Reno, Nevada, 89521, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.